A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.
Aug 27, 2020
0
100
We tend to assume disseminating public health messages is solely the role of public servants such as Victorian chief medical officer Brett Sutton and his former federal counterpart Brendan Murphy, both of whom have become ...
Aug 26, 2020
0
0
Preclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show positive results that appear to distinguish this vaccine candidate from other vaccine candidates that are currently in advanced ...
Aug 25, 2020
0
32
A senior Catholic archbishop has warned he is "deeply troubled" by Australia's vaccine deal with AstraZeneca, saying the potential vaccine uses a fetal cell line that creates an "ethical quandary" for Christians.
Aug 24, 2020
0
2
Shares of German biotech company CureVac, which is developing a leading coronavirus vaccine candidate, rocketed Friday in its first day of trading in New York after raising more than $200 million in an initial public offering.
Aug 15, 2020
0
4
The WHO on Thursday urged countries to invest billions of dollars in searching for COVID-19 vaccines and treatments—calling it a snip compared to the vast economic cost of the coronavirus crisis.
Aug 13, 2020
0
0
PDS Biotechnology, a clinical stage immunotherapy company, has announced positive results from preclinical testing conducted at the University of Kentucky College of Medicine of its COVID-19 vaccine candidate, PDS0203.
Aug 13, 2020
0
1
(HealthDay)—A vaccine based on cutting-edge RNA gene technology showed promising potency against the new coronavirus in an early trial, scientists report.
Aug 12, 2020
0
2251
An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis. The vaccine, which is made from a mild ...
Aug 12, 2020
0
103
President Donald Trump on Tuesday announced a $1.5 billion contract with US biotech company Moderna for 100 million doses of an eventual coronavirus vaccine, the sixth such deal reached since May.
Aug 12, 2020
0
2
